Last reviewed · How we verify
NCT03966404
EyeBOX Concussion Study and Registry
trial testing EyeBOX device in Concussion, Brain in 200 participants. Completed in 1 June 2023.
1 June 2023
Quick facts
| Lead sponsor | Oculogica, Inc. |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 200 |
| Start date | 5 August 2019 |
| Primary completion | 1 June 2023 |
| Estimated completion | 1 June 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- EyeBOX device
Conditions studied
- Concussion, Brain — all drugs for Concussion, Brain →
- Mild Traumatic Brain Injury — all drugs for Mild Traumatic Brain Injury →
Sponsor
Oculogica, Inc.
Who can join
Eligibility, any sex, with Concussion, Brain or Mild Traumatic Brain Injury. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this study is to further evaluate eye movements as an aid in the diagnosis of concussion / mTBI and the utility of eye movement assessment in the monitoring of symptoms over time after an initial diagnosis of concussion.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03966404
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Concussion, Brain
Currently open trials in the same condition.
- NCT06956417 — REhabilitation of MEMory Symptoms After BRain Concussion · NA · recruiting
- NCT06739785 — Turkish Translation of SportsConcussion Assesment Tool 6 · active not recruiting
- NCT06270290 — The COSP-RBD Study: Concussions and Contact Sports in RBD vs Controls · recruiting
- NCT06208813 — Creatine Supplementation in Concussion Recovery · NA · recruiting
- NCT06036147 — Concussion Health Improvement Program · NA · recruiting
Other Oculogica, Inc. trials
Trials by the same sponsor.
- NCT05527041 — A Highly Portable Device for Assessment of Mild Traumatic Brain Injury in Deployed and Far-Forward Settings · enrolling by invitation
- NCT04799093 — Eye Movement Tracking to Detect Impairment Due to Acute Cannabis Intoxication · completed
- NCT05047003 — Oculogica Portable EyeBOX Study · completed
- NCT03418753 — Non-invasive Diagnostic for Assessing Elevated Intracranial Pressure · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03966404 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Oculogica, Inc.
- Last refreshed: 7 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03966404.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing